Broach Lifecare Hospital Ltd (544231)
சுருக்கம்
நிகழ்வுகள்
- சமீபத்திய முடிவுகள்
- H1 FY27, filed 31 Oct 2026
- இயக்குநர் குழுக் கூட்ட அறிவிப்பு
- 31 அக். 2026
பங்குச் சந்தைத் தரவு. ஒவ்வொரு எண்ணும் அதன் சொந்தப் பக்கம் காட்டும் வடிவத்திலேயே; தேதிகள் தரவின் தேதிகள். தகவலுக்கு மட்டுமே, முதலீட்டு ஆலோசனை அல்ல.
📈 பங்கு விலை & நிகழ்வுகள்
H1 FY27 முடிவுகள்
Broach Lifecare Hospital Ltd reported H1 FY27 results on 31 Oct 2026: revenue ₹3.9 Cr (+48.5% year on year, +13.9% on the previous half-year), and net profit ₹0.1 Cr (-57.9% year on year); the operating margin was 11.3%.
| H1 FY27 (₹ கோடி) | மதிப்பு | YoY H1 FY26-உடன் | முந்தைய அரையாண்டுடன் ஒப்பீடு |
|---|---|---|---|
| வருவாய் | ₹3.9 | +48.5% | +13.9% |
| செயல்பாட்டு லாபம் | ₹0.4 | -15.8% | நஷ்டத்திலிருந்து |
| நிகர லாபம் | ₹0.1 | -57.9% | நஷ்டத்திலிருந்து |
| EPS (₹) | 0.21 | -58.8% | நஷ்டத்திலிருந்து |
| செயல்பாட்டு லாப வரம்பு | 11.3% | — | — |
- செயல்பாட்டு லாப வரம்பு 866 bps YoY குறைந்தது
லாபத்தின் தரம்: வரிக்கு முந்தைய ₹0.2 கோடி லாபத்தில், ₹0.2 கோடி (100%) முக்கிய வணிகத்திலிருந்து வந்தது; மீதம் பிற வருமானம் மற்றும் ஒருமுறை வரவுகளிலிருந்து வந்தது. முக்கிய லாபம் (செயல்பாட்டு லாபத்தில் வட்டி மற்றும் தேய்மானத்தைக் கழித்தது) YoY அடிப்படையில் -42.7% மாறியுள்ளது.
📢 சமீபத்திய கார்ப்பரேட் அறிவிப்புகள்
Broach Lifecare Hospital Limited submitted its statement of deviation or variation for the quarter ended September 30, 2026, regarding funds raised via its IPO. Out of the total ₹402 lakh raised on August 19, 2024, the company confirmed there is nil deviation from the stated objects. Under the machinery purchase object, ₹194.95 lakh has been utilized out of the allocated ₹262.45 lakh. The Audit Committee reviewed and approved the report with no adverse observations.
- Total funds raised through IPO amounted to ₹402 lakh with allotment date August 19, 2024
- ₹194.95 lakh utilized against an allocation of ₹262.45 lakh for purchase of medical machinery
- ₹75.0 lakh allocated towards medical tourism portal development
- Nil deviation or variation reported in the use of issue proceeds for the quarter ended September 30, 2026
Broach Lifecare Hospital Ltd has approved its unaudited standalone financial results for the half year ended September 30, 2026. The board meeting commenced at 2:00 p.m. and concluded at 3:00 p.m. on October 31, 2026. Detailed financial metrics such as revenue, margins, and profit were not included in the primary outcome letter extract. Investors will need to refer to the attached detailed financial tables to assess performance against its TTM revenue base of Rs 9 crore.
- Board approved unaudited standalone financial results for the half year ended September 30, 2026
- Meeting commenced at 2:00 p.m. and concluded at 3:00 p.m. on October 31, 2026
- Results received limited review report from the company's auditors
- Detailed P&L figures not stated in the outcome cover letter text
Broach Lifecare Hospital announced key operational expansions including cashless empanelment with ONGC and ESIC across industrial hubs like Ankleshwar and Dahej. The hospital also added a 5-bed Dialysis Unit, Cardiothoracic Surgery, and Urology under PMJAY scheme offerings. Additionally, it completed its Full NABH Accreditation inspection, with formal certification decision pending. For a company with TTM revenue of ₹9 Cr, institutional and scheme-based empanelments provide critical patient footfall volume.
- Empaneled with ONGC for cashless healthcare after obtaining Form 17/2 Income Tax Exemption
- Secured ESIC empanelment covering industrial hubs of Ankleshwar, Dahej, and Jhagadia GIDC
- Expanded PMJAY services by adding Cardiothoracic Surgery, Urology, and a 5-bed Dialysis Unit
- Completed Full NABH Accreditation inspection with decision outcome pending
Broach Lifecare Hospital Limited has scheduled a meeting of its Board of Directors on Saturday, September 5, 2026. The board will consider and approve the Board's Report along with annexures for FY 2025-26. Additionally, it will finalize the date, time, venue, and notice for the forthcoming Annual General Meeting (AGM) and appoint a secretarial auditor and e-voting scrutinizer. This is a standard administrative board meeting filing.
- Board meeting scheduled for Saturday, September 5, 2026
- Agenda includes approval of the Board's Report and annexures for FY 2025-26
- Board to finalize the AGM date, venue, notice, and appointment of Secretarial Auditor
- Appointment of Mr. Rahul S. Mithaiwala, Practicing Company Secretary, as e-voting scrutinizer
Broach Lifecare Hospital Limited announced the resignation of Ms. Swati Sharma from the position of Company Secretary and Compliance Officer (Key Managerial Personnel). The resignation took effect from the close of business hours on August 30, 2026. The stated reason for her departure is pre-occupation with other assignments. The company will need to appoint a successor to fulfill statutory compliance requirements.
- Ms. Swati Sharma resigned as Company Secretary and Compliance Officer (KMP)
- Resignation effective from the close of business hours on August 30, 2026
- Reason cited: Pre-occupation in other assignments
- Announcement filed with BSE under Regulation 30 on August 31, 2026
Broach Lifecare Hospital Ltd has appointed M/s. Rahul S. Mithaiwala & Co., Practicing Company Secretary, as the company's Secretarial Auditor for FY 2025-26. The appointment was approved by the Board of Directors at its meeting held on August 26, 2026, following the recommendation of the Audit Committee. This is a routine statutory compliance appointment under SEBI LODR and Companies Act requirements.
- Appointed M/s. Rahul S. Mithaiwala & Co. (COP: 17386, Peer Review No.: 1910/2022) as Secretarial Auditor
- Appointment approved at Board meeting held on August 26, 2026
- Auditor engagement is for the Financial Year 2025-26
Broach Lifecare Hospital Limited announced that its Board of Directors approved key management and compliance auditor changes on August 26, 2026. The Board took note of the resignation of Chief Financial Officer (CFO) Ms. Urvi Mrunal Hindia, citing personal reasons. Additionally, the Board noted the resignation of Secretarial Auditor M/s. N R Shah & Co. and approved the appointment of M/s. Rahul S. Mithaiwala & Co. as the new Secretarial Auditor for FY 2025-26.
- CFO Ms. Urvi Mrunal Hindia resigned due to personal reasons
- Secretarial Auditor M/s. N R Shah & Co. tendered resignation
- Appointed M/s. Rahul S. Mithaiwala & Co., Practicing Company Secretary, as Secretarial Auditor for FY 2025-26
- Board meeting commenced at 3:30 p.m. and concluded at 4:00 p.m. on August 26, 2026
Broach Lifecare Hospital Ltd has announced the resignation of its Chief Financial Officer (CFO), Ms. Urvi Mrunal Hindia, citing personal reasons. The resignation letter was submitted on August 24, 2026, and acknowledged on August 25, 2026. Her cessation will take effect at the close of business hours on August 31, 2026. The company, which generated TTM revenue of Rs 9 Cr, has not yet announced a successor for the key managerial role.
- Resignation letter submitted by CFO Ms. Urvi Mrunal Hindia on August 24, 2026
- Cessation takes effect from the close of business hours on August 31, 2026
- Reason cited for the resignation is personal reasons
- Company acknowledged the resignation on August 25, 2026
Broach Lifecare Hospital announced the resignation of its Secretarial Auditor, M/s. N R Shah & Co., effective from the closing of business hours on August 13, 2026. The auditor cited internal strategic realignment, restriction of secretarial audit services, and preoccupation with other professional assignments as reasons for stepping down. The company stated it will initiate the process to appoint a new Secretarial Auditor to fill the casual vacancy in accordance with the Companies Act, 2013.
- Resignation of Secretarial Auditor M/s. N R Shah & Co. effective August 13, 2026
- Reason cited includes internal strategic realignment and preoccupation with other assignments
- Company to initiate appointment process to fill casual vacancy per Companies Act, 2013
- Formal disclosure filed with BSE on August 25, 2026
நிறுவனச் சுயவிவரம்
நிதிச் செயல்திறன்
இந்த நிறுவனத்துக்கான நிதிப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
செயல்பாட்டு உந்துசக்திகள்
இந்த நிறுவனத்திற்கான செயல்பாட்டுப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
வியூக வளர்ச்சி
இந்த நிறுவனத்துக்கான வியூக வளர்ச்சிப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
வெளிப்புறக் காரணிகள்
இந்த நிறுவனத்துக்கு வெளிப்புறக் காரணிகளின் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
ஒழுங்குமுறை & நிர்வாகம்
இந்த நிறுவனத்திற்கான ஒழுங்குமுறைப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
அபாயப் பகுப்பாய்வு
இந்நிறுவனத்துக்கான அபாய பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
